UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
<TABLE>
<S> <C> <C> <C> <C> <C>
(Check One): / / Form 10-K / / Form 20-F / / Form 11-K /X/ Form 10-Q / / Form N-SAR
</TABLE>
For Period Ended: September 30, 2000
------------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
--------------------------
--------------------------------------------------------------------------------
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commissions has
verified any information contained herein.
--------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the item(s) to which the notification relates:
--------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
--------------------------------------------------------------------------------
Full Name of Registrant:
Luna Medical Technologies, Inc.
--------------------------------------------------------------------------------
Former Name if Applicable:
--------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
Suite 100-2296 McCallum Road
--------------------------------------------------------------------------------
City, State and Zip Code
Abbotsford, British Columbia, Canada V2S 3P4
--------------------------------------------------------------------------------
PART II - Rules 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box, if appropriate)
(a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
/X/ (b) The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be
filed on or before the fifteenth calendar day following the prescribe
due date; or the subject quarterly report of transition report on Form
10-Q, or portion thereof will be filed on or before the fifth calendar
day following the prescribed due date; and
(b) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
1
<PAGE>
PART III - NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period. (Attach Extra Sheets if Needed).
The Company has recently undergone a change in management and new management was
not able to complete the Company's financial statements for the period ending
September 30, 2000, in time for such statements to be reviewed by the Company's
auditor and filed with the Form 10QSB.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification.
Deron M. Colby (949) 660-9700
-------------------- --------- ----------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities and Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter
period that the registrant was required to file such report(s) been
filed? If the answer is no, identify report(s).
/X/ Yes / / No
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Luna Medical Technologies, Inc. has caused this notification to be signed on its
behalf by the undersigned, Thereunto duly authorized, in the City of Newport
Beach, California, on November 13, 2000.
Luna Medical Technologies, Inc.,
a Nevada Corporation
By: /s/ Dr. James Swanney
------------------------------
Dr. James Swanney
Its: President
INSTRUCTION: The form may be signed by an executive office of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
--------------------------------------------------------------------------------
ATTENTION:
Intentional misstatements or omissions of fact constitute Federal
Criminal Violations (See 18 U.S.C. 1001).
--------------------------------------------------------------------------------
2
